Cargando…
Infections at the nexus of metabolic-associated fatty liver disease
Metabolic-associated fatty liver disease (MAFLD) is a chronic liver disease that affects about a quarter of the world population. MAFLD encompasses different disease stadia ranging from isolated liver steatosis to non-alcoholic steatohepatitis (NASH), fibrosis, cirrhosis and hepatocellular carcinoma...
Autores principales: | Boeckmans, Joost, Rombaut, Matthias, Demuyser, Thomas, Declerck, Baptist, Piérard, Denis, Rogiers, Vera, De Kock, Joery, Waumans, Luc, Magerman, Koen, Cartuyvels, Reinoud, Rummens, Jean-Luc, Rodrigues, Robim M., Vanhaecke, Tamara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141380/ https://www.ncbi.nlm.nih.gov/pubmed/34027561 http://dx.doi.org/10.1007/s00204-021-03069-1 |
Ejemplares similares
-
COVID-19 and drug-induced liver injury: a problem of plenty or a petty point?
por: Boeckmans, Joost, et al.
Publicado: (2020) -
Flow cytometric quantification of neutral lipids in a human skin stem cell-derived model of NASH
por: Boeckmans, Joost, et al.
Publicado: (2020) -
Anti-NASH Drug Development Hitches a Lift on PPAR Agonism
por: Boeckmans, Joost, et al.
Publicado: (2019) -
Transcriptomics Reveals Discordant Lipid Metabolism Effects between In Vitro Models Exposed to Elafibranor and Liver Samples of NAFLD Patients after Bariatric Surgery
por: Boeckmans, Joost, et al.
Publicado: (2022) -
From NAFLD to MAFLD: Aligning Translational In Vitro Research to Clinical Insights
por: Gatzios, Alexandra, et al.
Publicado: (2022)